Does the media favor OSUR or QDEL?

In the previous week, QuidelOrtho had 1 more articles in the media than OraSure Technologies. MarketBeat recorded 4 mentions for QuidelOrtho and 3 mentions for OraSure Technologies. OraSure Technologies' average media sentiment score of 0.90 beat QuidelOrtho's score of 0.59 indicating that OraSure Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment OraSure Technologies 0 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive QuidelOrtho 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive

Is CERS or OSUR more profitable?

Cerus has a net margin of -4.41% compared to OraSure Technologies' net margin of -66.42%. Cerus' return on equity of -15.18% beat OraSure Technologies' return on equity. Company Net Margins Return on Equity Return on Assets Cerus -4.41% -15.18% -4.38% OraSure Technologies -66.42% -18.57% -15.71%

Does the media prefer CERS or OSUR?

In the previous week, Cerus had 2 more articles in the media than OraSure Technologies. MarketBeat recorded 5 mentions for Cerus and 3 mentions for OraSure Technologies. OraSure Technologies' average media sentiment score of 0.90 beat Cerus' score of 0.82 indicating that OraSure Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cerus 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive OraSure Technologies 0 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer OSUR or UTMD?

OraSure Technologies presently has a consensus price target of $3.00, suggesting a potential downside of 28.06%. Given OraSure Technologies' higher possible upside, equities research analysts clearly believe OraSure Technologies is more favorable than Utah Medical Products. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score OraSure Technologies 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Utah Medical Products 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media refer more to ANIK or OSUR?

In the previous week, OraSure Technologies had 2 more articles in the media than Anika Therapeutics. MarketBeat recorded 3 mentions for OraSure Technologies and 1 mentions for Anika Therapeutics. Anika Therapeutics' average media sentiment score of 0.94 beat OraSure Technologies' score of 0.90 indicating that Anika Therapeutics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Anika Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive OraSure Technologies 0 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

OraSure Technologies (OSUR) Competitors

$4.17 +0.22 (+5.57%)

Closing price 04:00 PM Eastern

Extended Trading

$4.35 +0.18 (+4.41%)

As of 05:31 PM Eastern

Compare

OSUR vs. QDEL, CERS, UTMD, ANIK, and WST

Should you buy OraSure Technologies stock or one of its competitors? MarketBeat compares OraSure Technologies with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with OraSure Technologies include QuidelOrtho (QDEL), Cerus (CERS), Utah Medical Products (UTMD), Anika Therapeutics (ANIK), and West Pharmaceutical Services (WST). These companies are all part of the "health care supplies" industry.

How does OraSure Technologies compare to QuidelOrtho?

OraSure Technologies (NASDAQ:OSUR) and QuidelOrtho (NASDAQ:QDEL) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, media sentiment, risk, valuation, institutional ownership, analyst recommendations and earnings.

OraSure Technologies has a beta of 1.02, indicating that its share price is 2% more volatile than the broader market. Comparatively, QuidelOrtho has a beta of 0.77, indicating that its share price is 23% less volatile than the broader market.

In the previous week, QuidelOrtho had 1 more articles in the media than OraSure Technologies. MarketBeat recorded 4 mentions for QuidelOrtho and 3 mentions for OraSure Technologies. OraSure Technologies' average media sentiment score of 0.90 beat QuidelOrtho's score of 0.59 indicating that OraSure Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
OraSure Technologies	0 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
QuidelOrtho	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive

93.5% of OraSure Technologies shares are held by institutional investors. Comparatively, 99.0% of QuidelOrtho shares are held by institutional investors. 3.9% of OraSure Technologies shares are held by insiders. Comparatively, 1.1% of QuidelOrtho shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

QuidelOrtho has a net margin of -45.57% compared to OraSure Technologies' net margin of -66.42%. QuidelOrtho's return on equity of 4.25% beat OraSure Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OraSure Technologies	-66.42%	-18.57%	-15.71%
QuidelOrtho	-45.57%	4.25%	1.56%

OraSure Technologies presently has a consensus price target of $3.00, indicating a potential downside of 28.06%. QuidelOrtho has a consensus price target of $14.88, indicating a potential downside of 2.78%. Given QuidelOrtho's higher probable upside, analysts plainly believe QuidelOrtho is more favorable than OraSure Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OraSure Technologies	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
QuidelOrtho	3 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

OraSure Technologies has higher earnings, but lower revenue than QuidelOrtho. OraSure Technologies is trading at a lower price-to-earnings ratio than QuidelOrtho, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OraSure Technologies	$115.02M	2.50	-$68.73M	-$1.04	N/A
QuidelOrtho	$2.73B	0.38	-$1.13B	-$17.82	N/A

Summary

QuidelOrtho beats OraSure Technologies on 8 of the 14 factors compared between the two stocks.

How does OraSure Technologies compare to Cerus?

Cerus (NASDAQ:CERS) and OraSure Technologies (NASDAQ:OSUR) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, media sentiment, earnings, profitability, valuation, analyst recommendations, institutional ownership and risk.

78.4% of Cerus shares are owned by institutional investors. Comparatively, 93.5% of OraSure Technologies shares are owned by institutional investors. 5.6% of Cerus shares are owned by company insiders. Comparatively, 3.9% of OraSure Technologies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Cerus presently has a consensus target price of $4.00, indicating a potential upside of 43.37%. OraSure Technologies has a consensus target price of $3.00, indicating a potential downside of 28.06%. Given Cerus' stronger consensus rating and higher probable upside, analysts plainly believe Cerus is more favorable than OraSure Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cerus	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
OraSure Technologies	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Cerus has a beta of 1.77, suggesting that its stock price is 77% more volatile than the broader market. Comparatively, OraSure Technologies has a beta of 1.02, suggesting that its stock price is 2% more volatile than the broader market.

In the previous week, Cerus had 2 more articles in the media than OraSure Technologies. MarketBeat recorded 5 mentions for Cerus and 3 mentions for OraSure Technologies. OraSure Technologies' average media sentiment score of 0.90 beat Cerus' score of 0.82 indicating that OraSure Technologies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cerus	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
OraSure Technologies	0 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Cerus has higher revenue and earnings than OraSure Technologies. Cerus is trading at a lower price-to-earnings ratio than OraSure Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cerus	$206.13M	2.71	-$15.63M	-$0.05	N/A
OraSure Technologies	$115.02M	2.50	-$68.73M	-$1.04	N/A

Cerus has a net margin of -4.41% compared to OraSure Technologies' net margin of -66.42%. Cerus' return on equity of -15.18% beat OraSure Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cerus	-4.41%	-15.18%	-4.38%
OraSure Technologies	-66.42%	-18.57%	-15.71%

Summary

Cerus beats OraSure Technologies on 13 of the 16 factors compared between the two stocks.

How does OraSure Technologies compare to Utah Medical Products?

OraSure Technologies (NASDAQ:OSUR) and Utah Medical Products (NASDAQ:UTMD) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, dividends, media sentiment, analyst recommendations, institutional ownership, earnings, risk and profitability.

In the previous week, OraSure Technologies had 3 more articles in the media than Utah Medical Products. MarketBeat recorded 3 mentions for OraSure Technologies and 0 mentions for Utah Medical Products. Utah Medical Products' average media sentiment score of 1.89 beat OraSure Technologies' score of 0.90 indicating that Utah Medical Products is being referred to more favorably in the news media.

Company	Overall Sentiment
OraSure Technologies	Positive
Utah Medical Products	Very Positive

93.5% of OraSure Technologies shares are owned by institutional investors. Comparatively, 69.6% of Utah Medical Products shares are owned by institutional investors. 3.9% of OraSure Technologies shares are owned by insiders. Comparatively, 8.0% of Utah Medical Products shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Utah Medical Products has lower revenue, but higher earnings than OraSure Technologies. OraSure Technologies is trading at a lower price-to-earnings ratio than Utah Medical Products, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OraSure Technologies	$115.02M	2.50	-$68.73M	-$1.04	N/A
Utah Medical Products	$38.52M	5.61	$11.29M	$3.38	20.12

Utah Medical Products has a net margin of 28.90% compared to OraSure Technologies' net margin of -66.42%. Utah Medical Products' return on equity of 9.13% beat OraSure Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OraSure Technologies	-66.42%	-18.57%	-15.71%
Utah Medical Products	28.90%	9.13%	8.86%

OraSure Technologies has a beta of 1.02, suggesting that its share price is 2% more volatile than the broader market. Comparatively, Utah Medical Products has a beta of 0.37, suggesting that its share price is 63% less volatile than the broader market.

OraSure Technologies presently has a consensus price target of $3.00, suggesting a potential downside of 28.06%. Given OraSure Technologies' higher possible upside, equities research analysts clearly believe OraSure Technologies is more favorable than Utah Medical Products.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OraSure Technologies	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Utah Medical Products	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Utah Medical Products beats OraSure Technologies on 10 of the 15 factors compared between the two stocks.

How does OraSure Technologies compare to Anika Therapeutics?

Anika Therapeutics (NASDAQ:ANIK) and OraSure Technologies (NASDAQ:OSUR) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, media sentiment, risk, valuation, dividends and earnings.

Anika Therapeutics has a beta of 0.23, suggesting that its stock price is 77% less volatile than the broader market. Comparatively, OraSure Technologies has a beta of 1.02, suggesting that its stock price is 2% more volatile than the broader market.

Anika Therapeutics has a net margin of -9.52% compared to OraSure Technologies' net margin of -66.42%. Anika Therapeutics' return on equity of -5.90% beat OraSure Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Anika Therapeutics	-9.52%	-5.90%	-4.52%
OraSure Technologies	-66.42%	-18.57%	-15.71%

Anika Therapeutics has higher earnings, but lower revenue than OraSure Technologies. Anika Therapeutics is trading at a lower price-to-earnings ratio than OraSure Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Anika Therapeutics	$112.82M	1.74	-$10.88M	-$0.79	N/A
OraSure Technologies	$115.02M	2.50	-$68.73M	-$1.04	N/A

Anika Therapeutics currently has a consensus price target of $17.00, suggesting a potential upside of 14.94%. OraSure Technologies has a consensus price target of $3.00, suggesting a potential downside of 28.06%. Given Anika Therapeutics' stronger consensus rating and higher probable upside, analysts clearly believe Anika Therapeutics is more favorable than OraSure Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Anika Therapeutics	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
OraSure Technologies	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

91.5% of Anika Therapeutics shares are held by institutional investors. Comparatively, 93.5% of OraSure Technologies shares are held by institutional investors. 12.1% of Anika Therapeutics shares are held by company insiders. Comparatively, 3.9% of OraSure Technologies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, OraSure Technologies had 2 more articles in the media than Anika Therapeutics. MarketBeat recorded 3 mentions for OraSure Technologies and 1 mentions for Anika Therapeutics. Anika Therapeutics' average media sentiment score of 0.94 beat OraSure Technologies' score of 0.90 indicating that Anika Therapeutics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Anika Therapeutics	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
OraSure Technologies	0 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Anika Therapeutics beats OraSure Technologies on 10 of the 16 factors compared between the two stocks.

How does OraSure Technologies compare to West Pharmaceutical Services?

OraSure Technologies (NASDAQ:OSUR) and West Pharmaceutical Services (NYSE:WST) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, media sentiment, dividends, profitability, analyst recommendations, valuation, institutional ownership and earnings.

OraSure Technologies has a beta of 1.02, meaning that its stock price is 2% more volatile than the broader market. Comparatively, West Pharmaceutical Services has a beta of 1.18, meaning that its stock price is 18% more volatile than the broader market.

West Pharmaceutical Services has a net margin of 16.85% compared to OraSure Technologies' net margin of -66.42%. West Pharmaceutical Services' return on equity of 19.03% beat OraSure Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OraSure Technologies	-66.42%	-18.57%	-15.71%
West Pharmaceutical Services	16.85%	19.03%	14.06%

OraSure Technologies presently has a consensus price target of $3.00, indicating a potential downside of 28.06%. West Pharmaceutical Services has a consensus price target of $331.91, indicating a potential upside of 4.90%. Given West Pharmaceutical Services' stronger consensus rating and higher probable upside, analysts plainly believe West Pharmaceutical Services is more favorable than OraSure Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OraSure Technologies	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
West Pharmaceutical Services	0 Sell rating(s)	3 Hold rating(s)	9 Buy rating(s)	2 Strong Buy rating(s)	2.93

West Pharmaceutical Services has higher revenue and earnings than OraSure Technologies. OraSure Technologies is trading at a lower price-to-earnings ratio than West Pharmaceutical Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OraSure Technologies	$115.02M	2.50	-$68.73M	-$1.04	N/A
West Pharmaceutical Services	$3.07B	7.27	$493.70M	$7.48	42.30

93.5% of OraSure Technologies shares are owned by institutional investors. Comparatively, 93.9% of West Pharmaceutical Services shares are owned by institutional investors. 3.9% of OraSure Technologies shares are owned by insiders. Comparatively, 0.6% of West Pharmaceutical Services shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, West Pharmaceutical Services had 18 more articles in the media than OraSure Technologies. MarketBeat recorded 21 mentions for West Pharmaceutical Services and 3 mentions for OraSure Technologies. West Pharmaceutical Services' average media sentiment score of 1.09 beat OraSure Technologies' score of 0.90 indicating that West Pharmaceutical Services is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
OraSure Technologies	0 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
West Pharmaceutical Services	11 Very Positive mention(s)	4 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

West Pharmaceutical Services beats OraSure Technologies on 16 of the 17 factors compared between the two stocks.

Get OraSure Technologies News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OSUR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

OSUR vs. The Competition

Export

Metric	OraSure Technologies	MED PRODUCTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$287.10M	$8.25B	$6.44B	$12.46B
Dividend Yield	N/A	2.61%	2.69%	5.22%
P/E Ratio	-4.01	15.68	23.87	24.36
Price / Sales	2.50	7.13	521.52	117.07
Price / Cash	N/A	17.10	41.27	57.13
Price / Book	0.88	3.63	9.99	6.73
Net Income	-$68.73M	$224.05M	$3.56B	$337.03M
7 Day Performance	-1.42%	0.30%	-0.89%	0.08%
1 Month Performance	N/A	N/A	N/A	-1.78%
1 Year Performance	43.79%	2.90%	28.77%	33.98%

OraSure Technologies Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
OSUR OraSure Technologies	2.0265 of 5 stars	$4.17 +5.6%	$3.00 -28.1%	+33.4%	$287.10M	$115.02M	N/A	840
QDEL QuidelOrtho	1.8378 of 5 stars	$13.27 +1.9%	$14.88 +12.1%	-55.1%	$887.85M	$2.73B	N/A	6,500	Gap Up
CERS Cerus	2.8275 of 5 stars	$2.84 -6.6%	$4.00 +40.8%	+84.7%	$609.12M	$206.13M	N/A	290	News Coverage Short Interest Increase
UTMD Utah Medical Products	1.3722 of 5 stars	$66.18 -0.4%	N/A	+17.0%	$211.58M	$37.53M	19.58	180	Positive News
ANIK Anika Therapeutics	2.3456 of 5 stars	$14.63 +0.7%	$17.00 +16.2%	+24.3%	$193.33M	$112.82M	N/A	300

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:OSUR) was last updated on 6/4/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

OraSure Technologies (OSUR) Competitors

OSUR vs. QDEL, CERS, UTMD, ANIK, and WST

How does OraSure Technologies compare to QuidelOrtho?

Summary

How does OraSure Technologies compare to Cerus?

Summary

How does OraSure Technologies compare to Utah Medical Products?

Summary

How does OraSure Technologies compare to Anika Therapeutics?

Summary

How does OraSure Technologies compare to West Pharmaceutical Services?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

OSUR vs. The Competition

OraSure Technologies Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

OraSure Technologies (OSUR) Competitors

OSUR vs. QDEL, CERS, UTMD, ANIK, and WST

How does OraSure Technologies compare to QuidelOrtho?

Which has more volatility & risk, OSUR or QDEL?

Does the media favor OSUR or QDEL?

Do institutionals & insiders believe in OSUR or QDEL?

Is OSUR or QDEL more profitable?

Do analysts prefer OSUR or QDEL?

Which has stronger earnings & valuation, OSUR or QDEL?

Summary

How does OraSure Technologies compare to Cerus?

Do institutionals and insiders believe in CERS or OSUR?

Do analysts recommend CERS or OSUR?

Which has more volatility & risk, CERS or OSUR?

Does the media prefer CERS or OSUR?

Which has better valuation and earnings, CERS or OSUR?

Is CERS or OSUR more profitable?

Summary

How does OraSure Technologies compare to Utah Medical Products?

Does the media favor OSUR or UTMD?

Do institutionals and insiders have more ownership in OSUR or UTMD?

Which has stronger earnings & valuation, OSUR or UTMD?

Is OSUR or UTMD more profitable?

Which has more risk & volatility, OSUR or UTMD?

Do analysts prefer OSUR or UTMD?

Summary

How does OraSure Technologies compare to Anika Therapeutics?

Which has more volatility & risk, ANIK or OSUR?

Is ANIK or OSUR more profitable?

Which has preferable valuation & earnings, ANIK or OSUR?

Do analysts rate ANIK or OSUR?

Do insiders & institutionals hold more shares of ANIK or OSUR?

Does the media refer more to ANIK or OSUR?

Summary

How does OraSure Technologies compare to West Pharmaceutical Services?

Which has more volatility and risk, OSUR or WST?

Is OSUR or WST more profitable?

Do analysts recommend OSUR or WST?

Which has preferable earnings & valuation, OSUR or WST?

Do insiders and institutionals believe in OSUR or WST?

Does the media favor OSUR or WST?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

OSUR vs. The Competition

OraSure Technologies Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools